The protein binding substance Ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Kawel, Nadine ^a   Santini, Francesco ^a   Haas, Tanja ^a   Froehlich, Johannes M ^b   Bremerich, Jens ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Guerbet Switzerland   (Switzerland)

Author keywords

CMR; Diffuse myocardial fibrosis; Gadobenate dimeglumine; Ibuprofen; Interaction

Indexed keywords

GADOBENATE DIMEGLUMINE; IBUPROFEN; SERUM ALBUMIN;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DRUG EFFECT; ELECTRON SPIN RESONANCE; FEMALE; HEART MUSCLE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; VOLUNTEER;

ADULT; CONTRAST MEDIA; FEMALE; HEART; HUMANS; IBUPROFEN; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; TIME FACTORS;

EID: 84867386024     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-71     Document Type: Article

References (29)

1. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 1580 10.1016/j.jacc.2008.06.049 19007595
2. Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Been M, Thomson BJ, Smith MA, Ridgway JP, Douglas RH, Best JJ, Muir AL, Eur Heart J 1988 9 1250 1256 3234418 (Pubitemid 19010177)
3. Cardiovascular magnetic resonance in cardiac amyloidosis. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ, Circulation 2005 111 186 193 10.1161/01.CIR. 0000152819.97857.9D 15630027 (Pubitemid 40139730)
4. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU, AJR Am J Roentgenol 2006 187 630 W635 10.2214/AJR.05.1264 17114517
5. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging 2010 3 727 734 10.1161/CIRCIMAGING.108.842096 20855860
6. Assessment of nonischemic myocardial fibrosis. Jellis C, Martin J, Narula J, Marwick TH, J Am Coll Cardiol 2010 56 89 97 10.1016/j.jacc.2010.02.047 20620723
7. Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced t1 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, van der Geest RJ, Bonetti C, van der Velde ET, de Roos A, et al. Circ Cardiovasc Imaging 2012 5 51 59 10.1161/CIRCIMAGING.111.965608 22135399
8. Assessment of Diffuse Myocardial Fibrosis in Rats Using Small Animal Look-Locker Inversion Recovery (SALLI) T1 Mapping. Messroghli D, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, D OHI, Klein C, Berger F, Kuehne T: Circ Cardiovasc, Imaging 2011
9. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, et al. Circulation 2012 126 1206 1216 10.1161/CIRCULATIONAHA. 111.089409 22851543
10. T(1) mapping of the gadolinium-enhanced myocardium: Adjustment for factors affecting interpatient comparison. Gai N, Turkbey EB, Nazarian S, van der Geest RJ, Liu CY, Lima JA, Bluemke DA, Magn Reson Med 2011 65 1407 1415 10.1002/mrm.22716 21500267
11. Partition coefficients for gadolinium chelates in the normal myocardium: Comparison of gadopentetate dimeglumine and gadobenate dimeglumine. Kawel N, Nacif M, Santini F, Liu S, Bremerich J, Arai AE, Bluemke DA, J Magn Reson Imaging 2012 36 733 777 10.1002/jmri.23651 22488770
12. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. Aime S, Caravan P, J Magn Reson Imaging 2009 30 1259 1267 10.1002/jmri.21969 19938038
13. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ, Invest Radiol 2005 40 715 724 10.1097/01.rli.0000184756.66360.d3 16230904 (Pubitemid 41546838)
14. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Spinazzi A, Lorusso V, Pirovano G, Kirchin M, Acad Radiol 1999 6 282 291 10.1016/S1076-6332(99)80451-6 10228617 (Pubitemid 32673373)
15. MS-325: albumin-targeted contrast agent for MR angiography. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC, Radiology 1998 207 529 538 9577506 (Pubitemid 28259074)
16. Evidence for weak protein binding of commercial extracellular gadolinium contrast agents. Wang Y, Spiller M, Caravan P, Magn Reson Med 2010 63 609 616 10.1002/mrm.22214 20146229
17. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J, J Magn Reson Imaging 2007 26 1081 1086 10.1002/jmri.21119 17896383 (Pubitemid 47548170)
18. IceLuva: A scripting framework for MR image reconstruction based on free software. Santini FPS, Scheffler K, Concepts in Magnetic Resonance Part B: Magnetic Resonance Engineering 2011 39B 1 10 10.1002/cmr.b.20184
19. An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. Messroghli DR, Rudolph A, Abdel-Aty H, Wassmuth R, Kuhne T, Dietz R, Schulz-Menger J, BMC Med Imaging 2010 10 16 10.1186/1471-2342-10-16 20673350
20. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation 2002 105 539 542 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
21. Myocardial T1 and Extracellular Volume Fraction Mapping at 3 Tesla. Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA, Journal of cardiovascular magnetic resonance: official journal of the Society for Cardiovascular Magnetic Resonance 2011 13 75 10.1186/1532-429X-13-75
22. Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans. Sharma P, Socolow J, Patel S, Pettigrew RI, Oshinski JN, J Magn Reson Imaging 2006 23 323 330 10.1002/jmri.20504 16456820 (Pubitemid 43364058)
23. Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A, Acad Radiol 1998 5 Suppl 1 86 S89 discussion S93-S84 9561052
24. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, Siegler P, von der Lieth CW, Frank M, Lodemann KP, Essig M, Invest Radiol 2006 41 222 228 10.1097/01.rli.0000192421. 81037.d5 16481904 (Pubitemid 44406182)
25. Albumin-bound MRI contrast agents: the dilemma of the rotational correlation time. Vander Elst L, Laurent S, Bintoma HM, Muller RN, MAGMA 2001 12 135 140 11390269 (Pubitemid 32510132)
26. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P, Acc Chem Res 2009 42 851 862 10.1021/ar800220p 19222207
27. Impact of albumin on drug delivery-New applications on the horizon. Elsadek B, Kratz F, J Control Release 2012 157 4 28 10.1016/j.jconrel.2011.09. 069 21959118
28. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU, Radiology 2006 238 1004 1012 10.1148/radiol.2382041903 16424239 (Pubitemid 43289933)
29. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA, J Cardiovasc Magn Reson 2012 14 26 10.1186/1532-429X-14-26 22540153